Nutex Health Inc. (NASDAQ:NUTX - Get Free Report)'s stock price fell 7.7% on Wednesday . The stock traded as low as $125.75 and last traded at $127.27. 63,731 shares changed hands during trading, a decline of 28% from the average session volume of 88,864 shares. The stock had previously closed at $137.83.
Analysts Set New Price Targets
NUTX has been the subject of several recent analyst reports. Wall Street Zen lowered Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Thursday, May 22nd. Maxim Group increased their price objective on Nutex Health from $100.00 to $225.00 and gave the stock a "buy" rating in a research note on Tuesday, May 20th. Finally, Benchmark increased their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research note on Thursday, May 15th.
Check Out Our Latest Report on Nutex Health
Nutex Health Trading Down 2.6%
The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26. The company has a market cap of $637.23 million, a price-to-earnings ratio of 9.64 and a beta of -0.04. The business has a 50 day simple moving average of $135.41 and a 200 day simple moving average of $89.95.
Nutex Health (NASDAQ:NUTX - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, topping analysts' consensus estimates of ($0.15) by $2.71. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%. The company had revenue of $211.79 million during the quarter, compared to the consensus estimate of $81.09 million.
Hedge Funds Weigh In On Nutex Health
Several large investors have recently made changes to their positions in the company. American Century Companies Inc. bought a new stake in Nutex Health in the fourth quarter valued at about $1,362,000. Geode Capital Management LLC increased its holdings in Nutex Health by 12.6% in the fourth quarter. Geode Capital Management LLC now owns 34,125 shares of the company's stock valued at $1,082,000 after purchasing an additional 3,826 shares during the last quarter. World Investment Advisors bought a new stake in Nutex Health in the fourth quarter valued at about $217,000. Russell Investments Group Ltd. bought a new stake in Nutex Health in the fourth quarter valued at about $672,000. Finally, XTX Topco Ltd bought a new stake in shares of Nutex Health in the fourth quarter worth about $251,000. Institutional investors and hedge funds own 5.32% of the company's stock.
Nutex Health Company Profile
(
Get Free Report)
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Further Reading
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
